The Legal Law of Gravity
Saturday, January 28th, 2006The bidding war for Guidant Corporation came to an end this week when Boston Scientific Corp. caught the wedding bouquet after Johnson & Johnson elected not to counter Boston’s $27 billion bid.
Yesterday, however, the legal liabilities that have dogged Guidant since last year reared their ugly head again. The Food and Drug Administration issued a warning letter about “systemic” quality control violations at three Boston Scientific plants. In response to the news Boston Scientific’s stock sank nearly 7% to $21.63.
Unfortunately, the Guidant transaction continues to teach us lessons about the consequences of poor legal literacy:
- legal liabilities, whether the product recall costs associated with defective products or regulatory compliance failures, impact the bottom line,
- financial markets are ruthless about perceptions of value and don’t wait for due process (see further the recent Livedoor case),
- discounted legal risk leads to self-defeating math and decision making biases whose fragile construct collapses when contradictory evidence surfaces and reaches the top of mind.
It just goes to show how regulatory compliance issues and product liability go to the heart of a business model and its sustainability. They should not be relegated to an ancillary housekeeping status.